Stereotactic body radiation therapy for the treatment of localized prostate cancer in men with underlying inflammatory bowel disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1748-717X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Stereotactic body radiation therapy for the treatment of localized prostate cancer in men with underlying inflammatory bowel disease ; volume:16 ; number:1 ; day:9 ; month:7 ; year:2021 ; pages:1-9 ; date:12.2021
Radiation oncology ; 16, Heft 1 (9.7.2021), 1-9, 12.2021
- Creator
-
Lischalk, Jonathan W.
Blacksburg, Seth
Mendez, Christopher
Repka, Michael
Sanchez, Astrid
Carpenter, Todd
Witten, Matthew
Garbus, Jules E.
Evans, Andrew
Collins, Sean P.
Katz, Aaron
Haas, Jonathan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13014-021-01850-1
- URN
-
urn:nbn:de:101:1-2021101611262960000828
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lischalk, Jonathan W.
- Blacksburg, Seth
- Mendez, Christopher
- Repka, Michael
- Sanchez, Astrid
- Carpenter, Todd
- Witten, Matthew
- Garbus, Jules E.
- Evans, Andrew
- Collins, Sean P.
- Katz, Aaron
- Haas, Jonathan
- SpringerLink (Online service)
Other Objects (12)
Stereotactic body radiotherapy for localized prostate cancer – 5-year efficacy results
Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer
Rectal endoscopy findings following stereotactic body radiation therapy for clinically localized prostate cancer
Safety of stereotactic body radiation therapy for localized prostate cancer without treatment planning MRI
Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience
Prostate-specific antigen kinetics after stereotactic body radiotherapy for localized prostate cancer: a scoping review and meta-analysis
Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
Robotic stereotactic body radiotherapy for localized prostate cancer: final analysis of the German HYPOSTAT trial
Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years
Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial
Stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer: toxicity profile and early oncologic outcomes
Stereotactic body radiotherapy for localized prostate cancer – 5-year efficacy results
Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer
Rectal endoscopy findings following stereotactic body radiation therapy for clinically localized prostate cancer
Safety of stereotactic body radiation therapy for localized prostate cancer without treatment planning MRI
Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience
Prostate-specific antigen kinetics after stereotactic body radiotherapy for localized prostate cancer: a scoping review and meta-analysis
Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
Robotic stereotactic body radiotherapy for localized prostate cancer: final analysis of the German HYPOSTAT trial
Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years
Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial
Stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer: toxicity profile and early oncologic outcomes
Stereotactic body radiotherapy for localized prostate cancer – 5-year efficacy results
Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer
Rectal endoscopy findings following stereotactic body radiation therapy for clinically localized prostate cancer
Safety of stereotactic body radiation therapy for localized prostate cancer without treatment planning MRI
Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience
Prostate-specific antigen kinetics after stereotactic body radiotherapy for localized prostate cancer: a scoping review and meta-analysis
Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
Robotic stereotactic body radiotherapy for localized prostate cancer: final analysis of the German HYPOSTAT trial
Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years
Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial